Piper Jaffray Upgrades Endo Pharmaceuticals Holdings Inc (ENDP) to Overweight

Go back to Piper Jaffray Upgrades Endo Pharmaceuticals Holdings Inc (ENDP) to Overweight

Cantor Fitzgerald Upgrades Endo Health (ENDP) to Hold

October 13, 2014 7:36 AM EDT

Cantor Fitzgerald upgraded Endo Health (NASDAQ: ENDP) from Sell to Hold.

Analyst Irina Rivkind Koffler said, "Though we take a conservative view of Auxilium's portfolio, we believe that Endo can attain +6.7% EPS accretion in 2015, with longer-term increases in EBITDA to facilitate... More

MKM Partners Downgrades Auxilium Pharmaceuticals (AUXL) to Neutral

October 10, 2014 7:04 AM EDT

MKM Partners downgraded Auxilium Pharmaceuticals (NASDAQ: AUXL) from Buy to Neutral.

For an analyst ratings summary and ratings history on Auxilium Pharmaceuticals click here. For more ratings news on Auxilium Pharmaceuticals click here.

Shares of Auxilium Pharmaceuticals closed at $32.44 yesterday.

... More

Endo Int'l (ENDP) to Acquire Auxilium (AUXL) in $2.6B Deal

October 9, 2014 6:31 AM EDT

Endo Int'l (NASDAQ: ENDP) and Auxilium Pharmaceuticals, Inc. (NASDAQ: AUXL) announced that they have entered into a definitive agreement under which Endo will acquire all of the outstanding shares of common stock of Auxilium for a per share consideration of $33.25 in a cash and stock transaction. The boards of directors of both companies have unanimously approved the transaction, which is valued at $2.6 billion, including the repayment and assumption of debt. The transaction will include an election mechanism for Auxilium stockholders to elect cash and stock, all-stock or all-cash... More